You are in: eMedicine Specialties > Emergency Medicine > TRAUMA AND ORTHOPEDICS Gamekeeper ThumbArticle Last Updated: Apr 9, 2008AUTHOR AND EDITOR INFORMATIONAuthor: Michael A Secko IV, MD, Clinical Assistant Instructor, Staff Physician, Clinical Assistant Instructor, Department of Emergency Medicine, Kings County Hospital, State University of New York Downstate Medical Center Coauthor(s): Mark A Silverberg, MD, FACEP, MMB, Assistant Professor, Assistant Residency Director, Department of Emergency Medicine, State University of New York Downstate College of Medicine; Consulting Staff, Department of Emergency Medicine, Staten Island University Hospital, Kings County Hospital, University Hospital, State University of New York Downstate at Brooklyn; Joseph Kim, MD, Chairman, Department of Emergency Medicine, Western Medical Center; Clinical Instructor, University of California at Irvine Editors: Robert M McNamara, MD, FAAEM, Professor of Emergency Medicine, Temple University; Chief, Department of Internal Medicine, Section of Emergency Medicine, Temple University Hospital; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Eric Legome, MD, Residency Director, Assistant Professor of Emergency Medicine, Department of Emergency Medicine New York University, New York University Hospital, Bellevue Hospital Center, Manhattan VA; John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center; Rick Kulkarni, MD, Medical Director, Assistant Professor of Surgery, Section of Emergency Medicine, Yale-New Haven Hospital Author and Editor Disclosure Synonyms and related keywords: skier thumb, skier's thumb, injury to ulnar collateral ligament, UCL, hyperabduction of thumb, gamekeeper's thumb INTRODUCTIONBackgroundGamekeeper's thumb was originally described by Campbell in 1955 when he reported chronic laxity of the ulnar collateral ligament (UCL) of the thumb in 24 Scottish gamekeepers. The injury occurred as gamekeepers sacrificed wounded rabbits and other small game by breaking their necks between the ground and their thumbs and index fingers. Today, this injury is more a result of delayed treatment of an acute injury. The alternative term skier's thumb was popularized by Gerber et al and has become more synonymous with an acute injury. A significant proportion of these injuries are a result of fall or blows to the thumbs. One of the common mechanisms is a skier landing against the ski pole or ground while the thumb is abducted causing a valgus force on the thumb. PathophysiologyThe metacarpophalangeal (MCP) joint is a diarthrodial joint with the metacarpal head stabilized by ligamentous and musculotendinous attachments. The thumb MCP joint is capable of motion predominately in flexion and extension with a limited degree of rotation. The ulnar collateral ligament provides static stabilization of the thumb MCP joint. The UCL consists of both a proper ligament and an accessory ligament. The proper is taut in flexion, while the accessory is taut in extension. The dynamic stabilizers are the intrinsic and extrinsic muscles of the thumb or most notably the adductor pollicis muscle. Dorsally, this muscle expands to form the adductor aponeurosis lying superficial to the UCL. Chronic laxity of the UCL results from repetitive lateral stress applied to the abducted MCP joint, in particular, the stabilizing ligaments on the ulnar side of the thumb MCP joint. Subsequent instability of the first MCP joint can result from the chronic laxity of the UCL and moreover, lead to functional disability such as weakness of pincer grasp and arthritis. An acute injury results from a sudden forced abduction stress at the MCP, particularly a fall against a ski pole or the ground. The distal attachment on the proximal phalanx is the most frequent site of rupture. The UCL may even avulse a small portion of the proximal phalanx at its insertion site. The rate of associated fractures in the skeletally mature varies from 23-50% of patients treated operatively. A Stener lesion occurs when the ruptured end of the UCL retracts and becomes abnormally displaced proximal to the adductor aponeurosis and may be palpated clinically on the ulnar side of the MCP joint. Proper anatomical alignment and healing becomes impeded because the adductor aponeurosis becomes interposed between the sites of insertion on the proximal phalanx with the ruptured end. This lesion can also be associated with a fracture as well. In the pediatric population, epiphyseal fusion of the proximal phalanx occurs in those aged 16-18 years. Ulnar collateral ligament ruptures of the thumb MCP joint in children are usually associated with epiphyseal fractures (Salter-Harris III) of the proximal phalanx. FrequencyUnited StatesThe incidence is increased in skiers. This common injury can also be sustained while playing football or rugby. Some instances of skier's thumb injuries are reported in sports with direct ball-to-thumb impact, such as volleyball. Gripped object sports cannot be implicated as the lone risk factor since thumb injuries are not common in sports such as lacrosse, hockey, or tennis. Ulnar collateral injuries have been reported in cases of people falling on outstretched hands with the thumb without reports of gripping any handle. Skier's thumb is the most common upper extremity injury in skiing and is second only to medial collateral ligament (MCL) injury of the knee. Reported injury rates in downhill skiing vary between 2.3 and 4.4 per 1000 skiing days. Of these, between 7% and 9.5% are injuries to the UCL. The incidence of Stener lesion–diagnosed definitively during surgery—was first noted in 64% of patients with clinical UCL injuries. Subsequent studies report between 14% and 87% of patients. Mortality/MorbidityDisruption of the UCL leads to instability of the first MCP joint. This results in poor pincer grasp and opposition and can ultimately lead to degenerative arthritic changes and difficulty carrying on the activities of daily living secondary to chronic pain. If the diagnosis is missed or the injury is not treated properly, enduring pain, weak pincer grasp, or arthritis may result. CLINICALHistory
Physical
CausesFall onto outstretched hand causing a forced abduction and extension of the thumb DIFFERENTIALSArthritis, Rheumatoid Fractures, Hand
|
| Drug Name | Ibuprofen (Ibuprin, Advil, Motrin) |
|---|---|
| Description | Usually DOC for treatment of mild to moderate pain, if no contraindications exist. Inhibits inflammatory reactions and pain probably by decreasing the activity of the enzyme cyclooxygenase, which results in prostaglandin synthesis. |
| Adult Dose | 400 mg PO q4-6h, 600 mg q6h, or 800 mg q8h while symptoms persist; not to exceed 3.2 g/d |
| Pediatric Dose | <6 months: Not established 6 months to 12 years: 20-40 mg/kg/d PO divided tid/qid >12 years: Administer as in adults |
| Contraindications | Documented hypersensitivity; peptic ulcer disease, recent GI bleeding or perforation, renal insufficiency, or high risk of bleeding |
| Interactions | Coadministration with aspirin increases risk of inducing serious NSAID-related adverse effects; probenecid may increase concentrations and toxicity of NSAIDs; may decrease effect of hydralazine, captopril, and beta-blockers; may decrease diuretic effects of furosemide and thiazides; monitor PT closely (instruct patients to watch for signs of bleeding); may increase risk of methotrexate toxicity; phenytoin levels may be increased when administered concurrently |
| Pregnancy | B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals D - Fetal risk shown in humans; use only if benefits outweigh risk to fetus |
| Precautions | Caution in congestive heart failure, hypertension, and decreased renal and hepatic function; caution in anticoagulation abnormalities or during anticoagulant therapy |
| Drug Name | Acetaminophen (Tylenol, Panadol, Aspirin-free Anacin) |
|---|---|
| Description | DOC for treating mild pain in patients with documented hypersensitivity to aspirin or NSAIDs, those with upper GI disease, or who take oral anticoagulants. |
| Adult Dose | 325-1000 mg PO q4-6h; not to exceed 4 g/d |
| Pediatric Dose | <12 years: 10-15 mg/kg/dose PO q4-6h; not to exceed 2.6 g/d >12 years: 325-650 mg PO q4h; not to exceed 5 doses/d |
| Contraindications | Documented hypersensitivity; known G-6-P deficiency |
| Interactions | Rifampin can reduce analgesic effects of acetaminophen; coadministration with barbiturates, carbamazepine, hydantoins, and isoniazid may increase hepatotoxicity |
| Pregnancy | B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals |
| Precautions | Hepatotoxicity possible in chronic alcoholics following various dose levels; severe or recurrent pain or high or continued fever may indicate a serious illness; acetaminophen is contained in many OTC products and combined use with these products may result in cumulative acetaminophen doses exceeding recommended maximum dose |
| Drug Name | Naproxen (Anaprox, Naprelan, Naprosyn) |
|---|---|
| Description | Used for relief of mild to moderate pain. Inhibits inflammatory reactions and pain by decreasing activity of the enzyme cyclooxygenase, which results in prostaglandin synthesis. |
| Adult Dose | 500 mg PO followed by 250 mg q6-8h; not to exceed 1.25 g/d; may increase to 1.5 g/d for limited periods |
| Pediatric Dose | <2 years: Not established >2 years: 2.5 mg/kg/dose PO; not to exceed 10 mg/kg/d |
| Contraindications | Documented hypersensitivity; peptic ulcer disease; recent GI bleeding or perforation; renal insufficiency |
| Interactions | Coadministration with aspirin increases risk of inducing serious NSAID-related adverse effects; probenecid may increase concentrations and toxicity of NSAIDs; may decrease effect of hydralazine, captopril, and beta-blockers; may decrease diuretic effects of furosemide and thiazides; monitor PT closely (instruct patients to watch for signs of bleeding); may increase risk of methotrexate toxicity; phenytoin levels may be increased when administered concurrently |
| Pregnancy | B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals D - Fetal risk shown in humans; use only if benefits outweigh risk to fetus |
| Precautions | Acute renal insufficiency, interstitial nephritis, hyperkalemia, hyponatremia, and renal papillary necrosis may occur; patients with preexisting renal disease or compromised renal perfusion risk acute renal failure; leukopenia occurs rarely, is transient, and usually returns to normal during therapy; persistent leukopenia, granulocytopenia, or thrombocytopenia warrants further evaluation and may require discontinuation of drug |
| Drug Name | Ketoprofen (Oruvail, Orudis, Actron) |
|---|---|
| Description | Used to relieve mild to moderate pain and inflammation. Initially administer small dosages to patients with a small body size, elderly patients, and those with renal or liver disease. Doses higher than 75 mg do not increase therapeutic effects. Administer high doses with caution, and closely observe patients for response. |
| Adult Dose | 25-50 mg PO q6-8h; not to exceed 300 mg/d |
| Pediatric Dose | <3 months: Not established 3 months to 12 years: 0.1-1 mg/kg PO q6-8h >12 years: 25-50 mg PO q6-8h; not to exceed 300 mg/d |
| Contraindications | Documented hypersensitivity |
| Interactions | Coadministration with aspirin increases risk of inducing serious NSAID-related adverse effects; probenecid may increase concentrations and toxicity of NSAIDs; may decrease effect of hydralazine, captopril, and beta-blockers; may decrease diuretic effects of furosemide and thiazides; monitor PT closely (instruct patients to watch for signs of bleeding); may increase risk of methotrexate toxicity; phenytoin levels may be increased when administered concurrently |
| Pregnancy | B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals D - Fetal risk shown in humans; use only if benefits outweigh risk to fetus |
| Precautions | Caution in congestive heart failure, hypertension, and decreased renal and hepatic function; caution in anticoagulation abnormalities or during anticoagulant therapy |
| Drug Name | Acetaminophen and codeine (Tylenol #3) |
|---|---|
| Description | Drug combination indicated for treatment of mild to moderate pain. |
| Adult Dose | Based on codeine content: 30-60 mg/dose PO q4-6h or 1-2 tab q4h; not to exceed 12 tab/d |
| Pediatric Dose | 0.5-1 mg/kg/dose based on codeine PO q4-6h; 10-15 mg/kg/dose based on acetaminophen content; not to exceed 2.6 g/d of acetaminophen |
| Contraindications | Documented hypersensitivity |
| Interactions | Toxicity increases with CNS depressants or tricyclic antidepressants |
| Pregnancy | C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus |
| Precautions | Caution in patients dependent on opiates because this substitution may result in acute opiate withdrawal symptoms; caution in severe renal or hepatic dysfunction |
| Drug Name | Oxycodone and acetaminophen (Percocet, Roxicet, Tylox) |
|---|---|
| Description | Drug combination indicated to relieve moderate to severe pain; DOC for aspirin-hypersensitive patients. |
| Adult Dose | 1-2 tab or cap PO q4-6h |
| Pediatric Dose | 0.05-0.15 mg/kg/dose PO oxycodone; not to exceed 5 mg/dose of oxycodone q4-6h |
| Contraindications | Documented hypersensitivity |
| Interactions | Phenothiazines may decrease analgesic effects of this medication; toxicity increases with coadministration of either CNS depressants or tricyclic antidepressants |
| Pregnancy | C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus |
| Precautions | Duration of action may increase in elderly patients; be aware of total daily dose of acetaminophen patient is receiving; do not exceed 4000 mg/d of acetaminophen; higher doses may cause liver toxicity |
| Drug Name | Hydrocodone bitartrate and acetaminophen (Vicodin) |
|---|---|
| Description | Drug combination indicated to relieve moderate to severe pain. |
| Adult Dose | 1-2 tab or cap PO q4-6h |
| Pediatric Dose | <12 years: 10-15 mg/kg/dose acetaminophen PO q4-6h; not to exceed 2.6 g/d of acetaminophen or 5 mg of hydrocodone bitartrate/dose >12 years: 750 mg acetaminophen PO q4h; not to exceed 5 doses/d acetaminophen or 10 mg of hydrocodone bitartrate/dose |
| Contraindications | Documented hypersensitivity; high altitude cerebral edema (HACE) or elevated intracranial pressure (ICP) |
| Interactions | Coadministration with phenothiazines may decrease analgesic effects; toxicity increases with CNS depressants or tricyclic antidepressants |
| Pregnancy | C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus |
| Precautions | Tablets contain metabisulfite, which may cause hypersensitivity; caution in patients dependent on opiates since this substitution may result in acute opiate withdrawal symptoms; caution in severe renal or hepatic dysfunction |
Article Last Updated: Apr 9, 2008